Top Globe News – Lifestyle
Author:
Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer
May 1, 2026
Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting
April 29, 2026
Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
April 28, 2026
Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences
April 13, 2026
Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
March 17, 2026
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
March 12, 2026